STAT+: Would drugmakers lower their insulin prices if Congress asks nicely?
WASHINGTON — After a yearslong, drawn-out debate over how to best lower patients’ prescription drug prices, two senators are workshopping a new idea to slash insulin costs: dangling incentives to convince drugmakers to lower prices of their own free will.
It’s largely based on a common complaint from drugmakers: that their sticker prices are sky-high because they have to pay insurers to get more favorable coverage for their medicines.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: Would drugmakers lower their insulin prices if Congress asks nicely? »